Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-10
DOI
10.1038/srep22850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
- (2016) R K Goudar Therapeutics and Clinical Risk Management
- The established and future biomarkers of malignant pleural mesothelioma
- (2015) V. Panou et al. CANCER TREATMENT REVIEWS
- Prognostic factors in malignant pleural mesothelioma
- (2015) Ben Davidson HUMAN PATHOLOGY
- Increasing Dietary Selenium Elevates Reducing Capacity and ERK Activation Associated with Accelerated Progression of Select Mesothelioma Tumors
- (2014) Aaron H. Rose et al. AMERICAN JOURNAL OF PATHOLOGY
- Neoadjuvant anti-tumor vaccination prior to surgery enhances survival
- (2014) Scott A Fisher et al. Journal of Translational Medicine
- Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines
- (2013) Vandana Relan et al. PLoS One
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group
- (2012) Aliya N. Husain et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation
- (2012) Jarrod D. Predina et al. CANCER BIOLOGY & THERAPY
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
- (2012) S. Jube et al. CANCER RESEARCH
- Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
- (2011) M. Carbone et al. CLINICAL CANCER RESEARCH
- Malignant mesothelioma: Facts, Myths, and Hypotheses
- (2011) Michele Carbone et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Evaluation of the Role of Tumor-Associated Macrophages in an Experimental Model of Peritoneal Carcinomatosis Using 18F-FDG PET
- (2011) L. Cottone et al. JOURNAL OF NUCLEAR MEDICINE
- Epithelial–mesenchymal transition in malignant mesothelioma
- (2011) Ambrogio Fassina et al. MODERN PATHOLOGY
- Malignant mesothelioma
- (2010) R. M. Rudd BRITISH MEDICAL BULLETIN
- Antigen quality determines the efficiency of antitumor immune responses generated in the absence of regulatory T cells
- (2010) A-S Bergot et al. CANCER GENE THERAPY
- Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity
- (2010) Joris D. Veltman et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation
- (2010) Haining Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
- (2009) F. Vandermeers et al. CLINICAL CANCER RESEARCH
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
- (2009) M. C. Crisanti et al. MOLECULAR CANCER THERAPEUTICS
- Advances in the systemic therapy of malignant pleural mesothelioma
- (2008) Dean A Fennell et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now